Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Background/Aim: Head and neck cancers account for 8% of all cancer cases worldwide. However, identifying the optimal treatment for recurrent or metastatic head and neck cancer (R/MHNSCC) has been challenging. The aim of this study was to evaluate the efficacy, safety, and prognostic factors of the o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: FUSHIMI, CHIHIRO, BABA, DAISUKE, MASUBUCHI, TATSUO, YAMAZAKI, MORIO, KITANI, YOSUKE, KITAJIMA, TATSUYA, TANAKA, JUNPEI, HANYU, KENJI, TANAKA, NARUHISA, MIURA, KOUKI, TADA, YUICHIRO
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652519/
https://ncbi.nlm.nih.gov/pubmed/32871796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12084
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados